Literature DB >> 18694930

The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity.

Asad Jan1, Ozgun Gokce, Ruth Luthi-Carter, Hilal A Lashuel.   

Abstract

Aggregation and fibril formation of amyloid-beta (Abeta) peptides Abeta40 and Abeta42 are central events in the pathogenesis of Alzheimer disease. Previous studies have established the ratio of Abeta40 to Abeta42 as an important factor in determining the fibrillogenesis, toxicity, and pathological distribution of Abeta. To better understand the molecular basis underlying the pathologic consequences associated with alterations in the ratio of Abeta40 to Abeta42, we probed the concentration- and ratio-dependent interactions between well defined states of the two peptides at different stages of aggregation along the amyloid formation pathway. We report that monomeric Abeta40 alters the kinetic stability, solubility, and morphological properties of Abeta42 aggregates and prevents their conversion into mature fibrils. Abeta40, at approximately equimolar ratios (Abeta40/Abeta42 approximately 0.5-1), inhibits (> 50%) fibril formation by monomeric Abeta42, whereas inhibition of protofibrillar Abeta42 fibrillogenesis is achieved at lower, substoichiometric ratios (Abeta40/Abeta42 approximately 0.1). The inhibitory effect of Abeta40 on Abeta42 fibrillogenesis is reversed by the introduction of excess Abeta42 monomer. Additionally, monomeric Abeta42 and Abeta40 are constantly recycled and compete for binding to the ends of protofibrillar and fibrillar Abeta aggregates. Whereas the fibrillogenesis of both monomeric species can be seeded by fibrils composed of either peptide, Abeta42 protofibrils selectively seed the fibrillogenesis of monomeric Abeta42 but not monomeric Abeta40. Finally, we also show that the amyloidogenic propensities of different individual and mixed Abeta species correlates with their relative neuronal toxicities. These findings, which highlight specific points in the amyloid peptide equilibrium that are highly sensitive to the ratio of Abeta40 to Abeta42, carry important implications for the pathogenesis and current therapeutic strategies of Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18694930      PMCID: PMC2661389          DOI: 10.1074/jbc.M803159200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  74 in total

1.  Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load.

Authors:  Jens Wiltfang; Hermann Esselmann; Mirko Bibl; Michael Hüll; Harald Hampel; Holger Kessler; Lutz Frölich; Johannes Schröder; Oliver Peters; Frank Jessen; Christian Luckhaus; Robert Perneczky; Holger Jahn; Magdalena Fiszer; Juan Manuel Maler; Rüdiger Zimmermann; Ralf Bruckmoser; Johannes Kornhuber; Piotr Lewczuk
Journal:  J Neurochem       Date:  2007-01-24       Impact factor: 5.372

2.  Evidence that A beta 42 is the real culprit in Alzheimer's disease.

Authors:  S G Younkin
Journal:  Ann Neurol       Date:  1995-03       Impact factor: 10.422

3.  Control of nucleation of protein crystals.

Authors:  D M Blow; N E Chayen; L F Lloyd; E Saridakis
Journal:  Protein Sci       Date:  1994-10       Impact factor: 6.725

4.  Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

Authors:  T Iwatsubo; A Odaka; N Suzuki; H Mizusawa; N Nukina; Y Ihara
Journal:  Neuron       Date:  1994-07       Impact factor: 17.173

5.  Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).

Authors:  S A Gravina; L Ho; C B Eckman; K E Long; L Otvos; L H Younkin; N Suzuki; S G Younkin
Journal:  J Biol Chem       Date:  1995-03-31       Impact factor: 5.157

6.  Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome.

Authors:  T Iwatsubo; D M Mann; A Odaka; N Suzuki; Y Ihara
Journal:  Ann Neurol       Date:  1995-03       Impact factor: 10.422

7.  Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

Authors:  A Lorenzo; B A Yankner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

8.  Biochemical evidence for the long-tail form (A beta 1-42/43) of amyloid beta protein as a seed molecule in cerebral deposits of Alzheimer's disease.

Authors:  A Tamaoka; T Kondo; A Odaka; N Sahara; N Sawamura; K Ozawa; N Suzuki; S Shoji; H Mori
Journal:  Biochem Biophys Res Commun       Date:  1994-11-30       Impact factor: 3.575

9.  How to measure and predict the molar absorption coefficient of a protein.

Authors:  C N Pace; F Vajdos; L Fee; G Grimsley; T Gray
Journal:  Protein Sci       Date:  1995-11       Impact factor: 6.725

10.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.

Authors:  R Sherrington; E I Rogaev; Y Liang; E A Rogaeva; G Levesque; M Ikeda; H Chi; C Lin; G Li; K Holman; T Tsuda; L Mar; J F Foncin; A C Bruni; M P Montesi; S Sorbi; I Rainero; L Pinessi; L Nee; I Chumakov; D Pollen; A Brookes; P Sanseau; R J Polinsky; W Wasco; H A Da Silva; J L Haines; M A Perkicak-Vance; R E Tanzi; A D Roses; P E Fraser; J M Rommens; P H St George-Hyslop
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

View more
  78 in total

1.  Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research.

Authors:  Asad Jan; Dean M Hartley; Hilal A Lashuel
Journal:  Nat Protoc       Date:  2010-06-03       Impact factor: 13.491

2.  Reactive oxidative species enhance amyloid toxicity in APP/PS1 mouse neurons.

Authors:  Bin Yang; Xiaqin Sun; Hilal Lashuel; Yan Zhang
Journal:  Neurosci Bull       Date:  2012-06       Impact factor: 5.203

3.  Interrelationship between Changes in the Amyloid β 42/40 Ratio and Presenilin 1 Conformation.

Authors:  Katarzyna Marta Zoltowska; Masato Maesako; Oksana Berezovska
Journal:  Mol Med       Date:  2016-07-05       Impact factor: 6.354

4.  Identification of novel γ-secretase-associated proteins in detergent-resistant membranes from brain.

Authors:  Ji-Yeun Hur; Yasuhiro Teranishi; Takahiro Kihara; Natsuko Goto Yamamoto; Mitsuhiro Inoue; Waltteri Hosia; Masakazu Hashimoto; Bengt Winblad; Susanne Frykman; Lars O Tjernberg
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

5.  The off-rate of monomers dissociating from amyloid-β protofibrils.

Authors:  Clara S R Grüning; Stefan Klinker; Martin Wolff; Mario Schneider; Küpra Toksöz; Antonia N Klein; Luitgard Nagel-Steger; Dieter Willbold; Wolfgang Hoyer
Journal:  J Biol Chem       Date:  2013-11-18       Impact factor: 5.157

6.  Discovery and structure activity relationship of small molecule inhibitors of toxic β-amyloid-42 fibril formation.

Authors:  Heiko Kroth; Annalisa Ansaloni; Yvan Varisco; Asad Jan; Nampally Sreenivasachary; Nasrollah Rezaei-Ghaleh; Valérie Giriens; Sophie Lohmann; María Pilar López-Deber; Oskar Adolfsson; Maria Pihlgren; Paolo Paganetti; Wolfgang Froestl; Luitgard Nagel-Steger; Dieter Willbold; Thomas Schrader; Markus Zweckstetter; Andrea Pfeifer; Hilal A Lashuel; Andreas Muhs
Journal:  J Biol Chem       Date:  2012-08-13       Impact factor: 5.157

Review 7.  Recent progress in understanding Alzheimer's β-amyloid structures.

Authors:  Marcus Fändrich; Matthias Schmidt; Nikolaus Grigorieff
Journal:  Trends Biochem Sci       Date:  2011-03-14       Impact factor: 13.807

Review 8.  Development and mechanism of γ-secretase modulators for Alzheimer's disease.

Authors:  Christina J Crump; Douglas S Johnson; Yue-Ming Li
Journal:  Biochemistry       Date:  2013-05-02       Impact factor: 3.162

9.  Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease.

Authors:  Erik Portelius; Ulf Andreasson; John M Ringman; Katharina Buerger; Jonny Daborg; Peder Buchhave; Oskar Hansson; Andreas Harmsen; Mikael K Gustavsson; Eric Hanse; Douglas Galasko; Harald Hampel; Kaj Blennow; Henrik Zetterberg
Journal:  Mol Neurodegener       Date:  2010-01-14       Impact factor: 14.195

10.  The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation?

Authors:  Kerensa Broersen; Frederic Rousseau; Joost Schymkowitz
Journal:  Alzheimers Res Ther       Date:  2010-07-14       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.